The Tuberculin Skin Test was developed in 1907. While it was highly effective in the US for most of the 20th century, it no longer meets the needs of the 21st century.
At the end of the presentation and discussion participants will be able to:
- Describe the diagnostic immunological testing options available for TB screening
- Outline current screening recommendations
- Evaluate the differences, advantages, and disadvantages among TB screening options
- Identify specific advantages of IGRA testing in challenging clinical, public health, and employee health settings in the US
(run time: presentation 42m21s, Q&A session 39m9s)